Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00714441 · ClinicalTrials.gov registry record · NA

Reducing Distress and Improving Self-Care in Diabetes

A NA study of Diabetes Type 2, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
392
Enrollment target
1
Study location

NCT00714441 is a NA study of Diabetes Type 2 that has completed, run by University of California, San Francisco. The registered enrollment target is 392 participants, below the 724-participant average among 21 other Diabetes Type 2 trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00714441, a NA study of Diabetes Type 2, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
392 participants
Enrollment target
1
Study location

Study Summary

To date, there have been few practical, evidenced based interventions that are directed at patients with Type II Diabetes who are experiencing depressed and/or emotional distress in primary care settings. This study will (1) combine two existing, evidenced-based, interventions (a computer automated, diabetes specific self-management program (CASM) vs. a self-care program plus a live problem solving distress-reduction program (CAPS) vs. a lifestyle and activities education program (LEAP-AHEAD)) into a practical, 3-arm clinical trial with a highly distressed multi-ethnic patient sample, and (2) evaluate the intervention using the RE-AIM framework, sharing the results through a comprehensive dissemination package. Hypothesis 1: The combined CASM and CAPS arms will be superior to the LEAP-AHEAD group on the primary outcomes at follow-up. Hypothesis 2: The CAPS arm will be superior to the CASM arm on primary outcomes at follow-up.

Conditions Studied

Interventions

  • BEHAVIORAL Lifestyle and Activities Education Program (LEAP-AHEAD)
  • BEHAVIORAL Computer Automated Self-Management (CASM)
  • BEHAVIORAL Computer Automated Self-Management and Problem Solving Therapy (CAPS)

Study Locations (1)

California

  • UC San Francisco, Family and Community Medicine Dept. - San Francisco

Trial Details

FieldValue
Enrollment Target 392 participants
Start Date 2008-07
Est. Completion 2011-11
Phase NA

What the Registry Record Tells You About NCT00714441

The ClinicalTrials.gov registry entry for NCT00714441 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 392 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 724-participant average among 21 other Diabetes Type 2 trials with a reported enrollment target (46% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Type 2 appearing as the primary indexed condition, and to 3 interventions - of which Lifestyle and Activities Education Program (LEAP-AHEAD) is the first listed.

NCT00714441 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00714441 about?

NCT00714441 is a clinical study titled "Reducing Distress and Improving Self-Care in Diabetes". To date, there have been few practical, evidenced based interventions that are directed at patients with Type II Diabetes who are experiencing depressed and/or emotional distress in primary care settings. This study will (1) combine two existing, evidenced-based, interventions (a computer automated,...

What is the current status of trial NCT00714441?

This trial is currently completed. It is a NA study. The enrollment target is 392 participants. The study started on 2008-07. Estimated completion is 2011-11.

What conditions does trial NCT00714441 study?

This clinical trial studies the following conditions: Diabetes Type 2.

What interventions are being tested in trial NCT00714441?

The interventions under investigation include: Lifestyle and Activities Education Program (LEAP-AHEAD) (BEHAVIORAL), Computer Automated Self-Management (CASM) (BEHAVIORAL), Computer Automated Self-Management and Problem Solving Therapy (CAPS) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00714441?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00714441 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.